Harvey Berger

Director/Board Member at

Dana-Farber Cancer Institute, Inc.

76 year

82 connections

Health Technology

Consumer Services

Health Services

Profile

Harvey J.
Berger was the founder of ARIAD Pharmaceuticals, Inc., founded in 1991, where the titles held included Chairman, President & Chief Executive Officer from 2004 to 2015.
Current jobs include Director at Cameron Boyce Foundation; Trustee at Dana-Farber Cancer Institute, Inc. since 2018; Member-Deans Council at Yale University since 2013; and Member-Deans Council at Yale School of Medicine.
Former jobs include Chairman, President & Chief Executive Officer at Kojin Therapeutics, Inc.; Executive Chairman-USA Region at Medinol Ltd.; and EVP, President-Research & Development Division at Centocor, Inc. from 1986 to 1991.
Education history includes undergraduate degree from Colgate University and doctorate from Yale School of Medicine.

Harvey Berger active positions

Companies	Position	Start
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Yale School of Medicine Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Dana-Farber Cancer Institute, Inc. Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients	Director/Board Member	2018-02-20
Cameron Boyce Foundation Cameron Boyce Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a foundation for research, education and awareness campaigns	Director/Board Member	-

All active positions of Harvey Berger

Former positions of Harvey Berger

Companies	Position	End
ARIAD PHARMACEUTICALS, INC.	Chief Executive Officer	2015-12-30
Centocor, Inc. Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products	Chief Tech/Sci/R&D Officer	1990-12-31
Kojin Therapeutics, Inc. Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation	Chief Executive Officer	-
Medinol Ltd. Medinol Ltd. Medical SpecialtiesHealth Technology Manufactures surgical devices for heart	Corporate Officer/Principal	-

See the detail of Harvey Berger's experience

Training of Harvey Berger

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Harvey Berger's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Centocor, Inc. Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products	Health Technology
ARIAD Pharmaceuticals, Inc. ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer	Health Technology
Dana-Farber Cancer Institute, Inc. Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients	Health Services
Colgate University Colgate University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Medinol Ltd. Medinol Ltd. Medical SpecialtiesHealth Technology Manufactures surgical devices for heart	Health Technology
Yale School of Medicine Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kojin Therapeutics, Inc. Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation	Health Technology
Cameron Boyce Foundation Cameron Boyce Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a foundation for research, education and awareness campaigns	Miscellaneous